Jonathan M. Nugent

Jonathan M. Nugent appears in our data through filings on Biocryst Pharmaceuticals Inc shares, published by SEC (Form 4). In total, 7 filings cover trades dated from 1 September 2006 to 31 July 2007.

On the open market, the record shows 2 purchases worth €2,951 and 4 sales worth €44k. On balance, insiders were net sellers of €42k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 1 option exercise. So far in 2007, the count stands at 2 purchases and no sales.

The record was last updated on 2 August 2007 with an open-market purchase (€1,471) in Biocryst Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.